Baclofen is used to treat muscle spasms caused due to cerebral palsy, multiple sclerosis, stroke or due to any other nerve or spinal cord disorders.
Baclofen: Muscle Relaxants
Baclofen is a muscle relaxant. It acts by increasing the effects of certain chemical messengers (such as GABA) in the spinal cord that induces muscle relaxation. As a result, it prevents muscle twitching, relieves pain caused due to muscle spasms and improves muscle movement.
Consult your doctor:
You are advised to take baclofen for the rest of your life for the treatment of muscle spasms that occur due to cerebral palsy, multiple sclerosis, stroke or any other nerve or spinal cord disorder. If you experience any of these symptoms, stop taking baclofen and consult your doctor.
You are also recommended to consult your doctor for medical advice about the dosage and side effects of baclofen. A consultation with a doctor is required to get your medical history, particularly if you have any health conditions or is taking any other medication.
You are also recommended to discuss the benefits and risks of taking baclofen for the treatment of muscle spasm and provide youreleredepartment with your prescribed dose and duration of treatment.
You are encouraged to report negative side effects of prescription products to the FDA. All products have0005b list of side effects.
Baclofen can help you to have an improved self-confidence, and you’re not alone.
If you are taking baclofen, it’s essential to talk to your doctor about this. Your doctor will also advise on the most appropriate treatment for your specific condition. For more information, including more options, visit.
Baclofen belongs to a class of drugs called skeletal muscle relaxants. It is also prescribed to people with severe spasticity and multiple sclerosis. Baclofen is a muscle relaxant and muscle relaxer that works by reducing spasticity and decreasing muscle spasms.
It works by increasing blood flow to the muscles, improving muscle function and mobility. It also reduces inflammation and pain and decreases fever.
You should take this medication regularly. It’s usually taken as a single dose. Your doctor will monitor your response and adjust the dose based on how much you are feeling.
Your doctor may have prescribed Baclofen for different conditions. For example, a person taking a class of drugs called muscle relaxants may be prescribed Baclofen for spasticity and/or multiple sclerosis.
Common side effects of Baclofen may include muscle pain, muscle weakness, and drowsiness. These side effects are more common in people who are taking the muscle relaxants.
The side effects of Baclofen may range from mild to more severe. You may experience muscle spasms, muscle rigidity, and muscle tenderness.
Less common side effects may include:
If you experience any side effects, contact your doctor immediately.
If you are taking baclofen or another muscle relaxant, you should avoid any other drugs while taking it. Taking medications that interact with baclofen can lead to serious side effects. This includes:
Baclofen can help improve muscle function and speed up your recovery. If you have any of these side effects, speak to your doctor about them. They may recommend an alternative drug.
In the U. K., Baclofen can also be prescribed for other conditions.
You should always read the medication label to ensure that you are using the drug safely. Before using this medication, you should tell your doctor about all of the medicines you take.
You should not take baclofen if you are also taking other drugs, such as lithium, warfarin, and diuretics (water pills).
Some people have reported experiencing side effects when taking Baclofen.
You should avoid using baclofen if you have a history of stroke, heart attack, or liver or kidney disease.
Baclofen is a muscle relaxant which has been used for many years in patients with spasticity of unknown etiology. Baclofen has been associated with several adverse effects such as headache, constipation, dry mouth, and dyspepsia. Although baclofen is usually well tolerated, it is important to recognize that the benefits of baclofen are not immediate. In the present study, we investigated the effects of baclofen on the renal clearance of baclofen, and the effect of baclofen administration on the serum baclofen levels in the rat.
This is a double-blind, randomized, crossover study performed on adult male Sprague-Dawley rats. The protocol was approved by the animal experimentation committee of the University of Pennsylvania, Inc., and was registered under theon 13/06/2008 in the US and theon 14/06/2009 in Europe.
The study protocol was approved by the animal experimentation committee of the University of Pennsylvania, Inc., and the animal experimentation committee of the National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA. The rat study was carried out in accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and the US National Library of Medicine (Leiden, the Netherlands), and approved by the Research Ethics Committee of the Faculty of Medicine at the University of Pennsylvania.
Following anesthesia with isoflurane, the rats were intracerebroventricularly perfused with phosphate-buffered saline (PBS) containing 5.4 mEq/L glutaraldehyde (G. P. H. E. G.). The spinal fluid was removed and then stored in a cool dark place at 37°C until preparation for the experiment.
The animals were weighed, then anesthetized with 0.02% pentobarbital (Pentobarbital Hydrochloride, Zoetis, the Netherlands) and then perfused with PBS. The perfused spinal fluid was collected in the intrathecal space (IT) and the tissue was removed with a filter paper at 1-mg/mL. Subsequently, the tissue was collected and frozen in a cryoprotectant containing 1.5% sucrose. The remaining tissue was then stored in a freezer at -80°C until further experiments.
The rat model was established with the use of the rat model of spasticity, described previously (, ). The spasticity was induced by administering 100 mg/kg of baclofen to be able to produce a spasm in the test area. The rats were anesthetized with ketamine and then placed in a prone position. The spinal fluid was obtained by collecting the subcutaneous tissue into 1.5 mL tubes, and then, the tubes were cooled and diluted in 1:10 dilution of the vehicle (0.9% NaCl solution). Following the diluted solution (0.9% NaCl), the rats were anesthetized with chloral hydrate (2%) and then anesthetized with ketamine and then placed in the same position. The spinal fluid was obtained by collecting the subcutaneous tissue into 1.5 mL tubes, and then, the tubes were cooled and diluted in 1:10 dilution of the vehicle. The rats were anesthetized with chloral hydrate and then anesthetized with ketamine and then placed in the same position.
This is a small-scale retrospective study of patients who developedRADAPA-relatedParkinsonism, including a sub-group of patients who had aT2D-specific syndrome (e.g., idiopathic tardive dyskinesia, postural dyskinesias) andMADRS-specific tardive dyskinesia (e.g., akathisia, akinesia, akinesisia, dystonia).
A sub-group of patients who developedwas treated with tetracyclines, including baclofen and diazepam. Tertiary-group patients who had a-specific syndrome were treated with baclofen and diazepam alone or in combination. Treatment was initiated with baclofen at doses of 20 mg, 25 mg, and 30 mg. Tertiary-group patients who were-specific tardive dyskinesias (TMD) and tardive dyskinesia (TD) were treated with baclofen and diazepam only. Patients who were-specific tardive dyskinesias (RHD) were treated with baclofen and diazepam only. Patients who had a-specific syndrome (T2S) were treated with tetracyclines. Patients who developed-related tardive dyskinesias (RTD) were treated with baclofen and diazepam alone or in combination.-specific syndrome (T2S) were treated with baclofen and diazepam only.
T2D is associated with tardive dyskinesia (TD) in patients who have a-specific syndrome (T2S).-related tardive dyskinesias are typically associated with TD and TD-related tardive dyskinesia (TD-TMD). TD-TMD can occur in patients who have a-related tardive dyskinesia (RHD). T2S is typically associated with TD-TMD and TD-TMD-associated TD-TMD-associated TD-TMD-associated TD-TMD-specific syndrome.
T2D-related tardive dyskinesias can occur in patients with aT2S is usually associated with tardive dyskinesia and TD-TMD. T2S is typically associated with TD-TMD and TD-TMD-associated tardive dyskinesia. T2D-TMD is associated with TD-TMD-associated tardive dyskinesia and TD-TMD-associated tardive dyskinesia.
T2D-related tardive dyskinesias (T2S) are typically associated with TD-TMD and TD-TMD-associated tardive dyskinesia.
T2D-TMD-associated tardive dyskinesias (T2S) are associated with TD-TMD and TD-TMD-associated tardive dyskinesia. T2D-TMD-associated tardive dyskinesia is associated with TD-TMD-associated tardive dyskinesia.
T2D-TMD-associated tardive dyskinesias are associated with TD-TMD and TD-TMD-associated tardive dyskinesia.
Generic name:Dosage form:tablet, pellet, syringeDrug class:
by Drugs.com. Last updated on Jan 15, 2025.
Baclofen pump is used for the treatment of spasticity associated with multiple sclerosis, spinal cord injuries, cerebral palsy and other spinal cord diseases. It is not for use in patients with severe spinal cord injuries, as it may cause hypotension.
What is Baclofen Pump?
Baclofen pump is a nonsteroidal anti-inflammatory drug (NSAID) that is used for the treatment of spasticity associated with multiple sclerosis, spinal cord injuries, cerebral palsy and other spinal cord diseases.
The usual adult dose for Baclofen pump is 100 milligrams once daily.
The use of Baclofen pump for the treatment of spasticity associated with multiple sclerosis, spinal cord injuries, cerebral palsy and other spinal cord diseases.
The dosage of Baclofen pump for the treatment of spasticity associated with multiple sclerosis, spinal cord injuries, cerebral palsy and other spinal cord diseases.
The drug class Baclofen is a nonsteroidal anti-inflammatory drug that is used to relieve spasticity. It is also used to reduce the pain in conditions such as multiple sclerosis, spinal cord injuries and cerebral palsy.
What are Baclofen Pump?
Baclofen pump is a medication used to treat spasticity in multiple sclerosis, spinal cord injuries, cerebral palsy and other spinal cord diseases.
The drug class Baclofen is a nonsteroidal anti-inflammatory drug (NSAID) that is used to relieve spasticity in multiple sclerosis, spinal cord injuries, cerebral palsy and other spinal cord diseases.
Stade de France Pharmacy